C3.ai, Inc. Faces Class Action Lawsuit over Alleged Misleading Investor Information

Strategic Insights -

C3.ai, a global artificial intelligence application software company, is at the center of a class action lawsuit filed on behalf of investors who purchased the company's securities between February 26, 2025, and August 8, 2025. The lawsuit alleges that C3.ai's management failed to disclose the impact of the Chief Executive Officer's health on the company's ability to close deals and execute on its profit and growth prospects. According to the complaint, C3.ai's poor sales results and lowered guidance for the full fiscal year 2026 were attributed to the CEO's health issues and the company's reorganization with new leadership.

Key Takeaways:

  • C3.ai, a global artificial intelligence application software company, is facing a class action lawsuit filed on behalf of investors who purchased the company's securities between February 26, 2025, and August 8, 2025.
  • The lawsuit alleges that C3.ai's management failed to disclose the impact of the Chief Executive Officer's health on the company's ability to close deals and execute on its profit and growth prospects.
  • Plaintiff alleges that on August 8, 2025, C3.ai attributed its poor sales results and lowered guidance for the full fiscal year 2026 to the CEO's health issues and the company's reorganization with new leadership.
  • The price of C3.ai common stock fell by over 25% from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, following the announcement of disappointing financial results.
  • The lawsuit claims that C3.ai's management was aware of the CEO's health issues but failed to disclose their impact on the company's business prospects.
  • C3.ai is a NYSE-listed company with securities traded on the NYSE under the ticker symbol AI.
  • The lawsuit is reportedly being led by Robbins LLP, a law firm specializing in securities class actions.
  • Aaron Dumas, Jr., an attorney at Robbins LLP, is handling the case and can be reached via email or by calling (800) 350-6003 to submit a form.

Statistics:

  • Over 25% decline in C3.ai common stock price from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025.
  • The decline occurred following the announcement of disappointing preliminary financial results for the first quarter of fiscal 2026 and reduced revenue guidance for the full fiscal year 2026.
  • August 8, 2025, marked the date when C3.ai attributed its poor sales results and lowered guidance to the CEO's health issues and the company's reorganization with new leadership.

Sources:

  • Robbins LLP news release, August 2025 (exact date not specified)
  • C3.ai, Inc. (NYSE: AI) press release, August 8, 2025
  • Robbins LLP, (800) 350-6003, email: [adumas@robbinshallum.com](mailto:adumas@robbinshallum.com)